Literature DB >> 11673540

Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver.

A E Matthews1, S R Weiss, M J Shlomchik, L G Hannum, J L Gombold, Y Paterson.   

Abstract

Intracerebral inoculation with mouse hepatitis virus strain A59 results in viral replication in the CNS and liver. To investigate whether B cells are important for controlling mouse hepatitis virus strain A59 infection, we infected muMT mice who lack membrane-bound IgM and therefore mature B lymphocytes. Infectious virus peaked and was cleared from the livers of muMT and wild-type mice. However, while virus was cleared from the CNS of wild-type mice, virus persisted in the CNS of muMT mice. To determine how B cells mediate viral clearance, we first assessed CD4(+) T cell activation in the absence of B cells as APC. CD4(+) T cells express wild-type levels of CD69 after infection in muMT mice. IFN-gamma production in response to viral Ag in muMT mice was also normal during acute infection, but was decreased 31 days postinfection compared with that in wild-type mice. The role of Ab in viral clearance was also assessed. In wild-type mice plasma cells appeared in the CNS around the time that virus is cleared. The muMT mice that received A59-specific Ab had decreased virus, while mice with B cells deficient in Ab secretion did not clear virus from the CNS. Viral persistence was not detected in FcR or complement knockout mice. These data suggest that clearance of infectious mouse hepatitis virus strain A59 from the CNS requires Ab production and perhaps B cell support of T cells; however, virus is cleared from the liver without the involvement of Abs or B cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673540     DOI: 10.4049/jimmunol.167.9.5254

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Control of central nervous system viral persistence by neutralizing antibody.

Authors:  Chandran Ramakrishna; Cornelia C Bergmann; Roscoe Atkinson; Stephen A Stohlman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 2.  Keeping it in check: chronic viral infection and antiviral immunity in the brain.

Authors:  Katelyn D Miller; Matthias J Schnell; Glenn F Rall
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

3.  Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

4.  Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence.

Authors:  Katherine C MacNamara; Ming Ming Chua; Joanna J Phillips; Susan R Weiss
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Both spike and background genes contribute to murine coronavirus neurovirulence.

Authors:  Kathryn T Iacono; Lubna Kazi; Susan R Weiss
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 6.  Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors:  Susan R Weiss; Sonia Navas-Martin
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

7.  Impaired immune responses following spinal cord injury lead to reduced ability to control viral infection.

Authors:  Katherine S Held; Oswald Steward; Caroline Blanc; Thomas E Lane
Journal:  Exp Neurol       Date:  2010-09-09       Impact factor: 5.330

8.  T helper cell- and CD40-dependent germline IgM prevents chronic virus-induced demyelinating disease.

Authors:  Cristina Gil-Cruz; Christian Perez-Shibayama; Sonja Firner; Ari Waisman; Ingo Bechmann; Volker Thiel; Luisa Cervantes-Barragan; Burkhard Ludewig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

9.  Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.

Authors:  Ming Ming Chua; Katherine C MacNamara; Lani San Mateo; Hao Shen; Susan R Weiss
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.